GENE ONLINE|News &
Opinion
Blog

Glioblastoma
Technology ChemotherapyBlood-Brain Barrier
Novel Technique to Deliver Chemotherapy Drug into Human Brains
2023-05-09
R&D Glioblastoma
Activating Cryptochrome Isoforms May Inhibit Glioblastoma Proliferation, Providing New Therapeutic Possibilities
2022-10-07
R&D Glioblastoma
Injectable Hydrogel Targets Macrophages and Stops the Relapse of Glioblastoma
2022-09-06
Trials & Approvals Glioblastoma
HebaBiz Biotech Obtains FDA Clearance to Trial Cancer Drug Against Aggressive Brain Tumor
2021-08-22
Trials & Approvals Immunotherapy
FDA Fast Tracks Celgene Spinoff’s NK Cell Therapy for Treating Aggressive Brain Tumor
2021-03-21
R&D siRNA
Scientists Successfully Use Gold-Nanoparticles to Deliver Novel Therapy for Brain Tumor
2021-03-16
Trials & Approvals Glioblastoma
China Approves Avastin’s New Indication
2020-09-25
Anti-cancer
Samsung Biologics Inks CDO Contract with PharmAbcine to Develop Novel Drug
2020-04-08
LATEST
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top